Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1989
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?B Pillon, B Dubois, G Cusimano, et al.
Neurology|March 1, 1997
Low-dose clozapine improves dyskinesias in Parkinson's diseaseF Durif, M Vidailhet, F Assal, et al.
Journal of Affective Disorders|May 1, 1983
Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparisonR Jouvent, P Abensour, A M Bonnet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1991
Does ageing aggravate parkinsonian disability?J Blin, B Dubois, A M Bonnet, et al.
Neuropsychologia|March 1, 1997
Memory for spatial location in 'de novo' parkinsonian patientsB Pillon, S Ertle, B Deweer, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxiaA M Bonnet, M Esteguy, G Tell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiologyR Marconi, D Lefebvre-Caparros, A M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspectsA M Bonnet, J Pichon, M Vidailhet, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 1, 1986
Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsyJ C Baron, B Mazière, C Loc'h, et al.
Pageof 7